Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer
DOI:
10.18632/aging.206210
Publication Date:
2025-02-27T16:25:08Z
AUTHORS (6)
ABSTRACT
Human Methyltransferase-like 16(METTL16) is an independent N6-methyladenosine (m6A) methyltransferase. Previous studies have proven METTL16 been linked with some types of cancers. However, comparative the relevance across diverse tumors remain sparse. We comprehensively investigated effect expression on tumor prognosis human malignancies by analyzing multiple cancer-related databases like Tumor Immune Estimation Resource (TIMER) and protein atlas (HPA). Bioinformatics data indicated that was overexpressed in most these significantly associated patients cancer, especially colorectal cancer (CRC). Subsequently, <i>In vitro</i> experiments, utility downregulation its could result reduced proliferation migration CRC cells. Our findings reveal novel insights into biological functions types, indicating serve as a prognostic biomarker plays important role cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....